Neutrophil polynuclear anticytoplasm antibodies in systemic vaculitides;Les anticorps anticytoplasme des polynucleaires neutrophiles au cours des vascularites systemiques

Revue des Maladies Respiratoires

Volumn 17, Issue 3, 2000, Pages 623-628

  Guillevin, L ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; BIOLOGICAL MARKER; CELL ADHESION MOLECULE;

ANTIBODY DETECTION; CELL ADHESION; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; LEUKOCYTE ACTIVATION; PATHOGENESIS; REVIEW; SERODIAGNOSIS; SYSTEMIC VASCULITIS; VASCULAR ENDOTHELIUM; WEGENER GRANULOMATOSIS; BLOOD; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENETICS; HUMAN; IMMUNOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; VASCULITIS;

EID: 0034201958     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. VAN DER WOUDE F, RASMUSSEN N, LOBATTO S et al. : Autoantibodies against neutrophils and monocytes : tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-9.
2. STEGEMAN C, COHEN TERVAERT J, KALLENBERG C : Anti-neutrophil cytoplasmic antibodies : tools for diagnosis and follow-up in systemic vasculitis. Ann Méd Interne 1994;145: 523-32.
3. JENNETTE JC, WILKMAN AS, FALK RJ : Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-30.
4. JENNETTE JC, FALK RJ : Antineutrophil cytoplasmic autoantibodies and associated diseases : a review. Am J Kidney Dis 1990;15:517-29.
5. GROSS WL, SCHMITT WH, CSERNOK E : ANCA and associated diseases : immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1-12.
6. COHEN TERVAERT J, MULDER L, STEGEMAN C et al. : Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993;52:115-20.
7. DUNA GF, COTCH MF, GALPERIN C, HOFFMAN DB, HOFFMAN GS : Wegener's granulomatosis : role of environmental exposures. Clin Exp Rheumatol 1998;16:669-74.
8. GUILLEVIN L, GUITTARD T, BLETRY O, GODEAU P, ROSENTHAL P : Systemic necrotizing angiitis with asthma : causes and precipitating factors in 43 cases. Lung 1987;165:165-72.
9. CSERNOK E, SCHMITT WH, ERNST M, BAINTON DF, GROSS WL : Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides. Adv Exp Med Biol 1993;336: 45-50.
10. CSERNOK E, LUDEMANN J, GROSS WL, BAINTON DF : Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Pathol 1990;137:1113-20.
11. CSERNOK E, ERNST M, SCHMITT W, BAINTON DF, GROSS WL : Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994;95: 244-50.
12. GROSS WL, TRABANDT A, CSERNOK E : Pathogenesis of Wegener's granulomatosis. Ann Méd Interne (Paris) 1998;149: 280-6.
13. DE BANDT M : Les ANCA (anticorps anti-cytoplasme des polynucléaires). Apport des ANCA à la compréhension des mécanismes pathogéniques des vascularites systémiques. Ann Méd Interne (Paris) 1997;148:542-62.
14. SHOENFELD Y, TOMER Y, BLANK M : A new expérimental model for Wegener's granulomatosis. Isr J Med Sci 1995;31: 13-6.
15. MCCLUSKEY RT : Immunopathogenetic mechanisms in renal disease. Am J Kidney Dis 1987;10:172-80.
16. RAO JK, WEINBERGER M, ODDONE EZ, ALLEN NB, LANDSMAN P, FEUSSNER JR : The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995;123:925-32.
17. YANG J, KETTRITIZ R, FALK R, JENNETTE J, GAIDO M : Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol 1996;149: 1617-26.
18. HAGEN EC, STEGEMAN CA, D'AMARO J et al. : Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis. Kidney Int 1995;48:801-5.
19. HALBWACHS ML, BESSOU G, LESAVRE P, LOPEZ S, WITKO SV : Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. Febs Lett 1995;374:29-33.
20. WITKO-SARSAT V, LESAVRE P, LOPEZ S et al. : A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 1998;10:1224-33.
21. JENNETTE JC, FALK RJ, ANDRASSY K et al. : Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
22. GROSS WL : Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am 1995;21:987-1011.
23. GROSS WL, CSERNOK E : Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995;7:11-9.
24. KALLENBERG CG, MULDER AH, TERVAERT JW : Antineutrophil cytoplasmic antibodies : a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992;93:675-82.
25. GUILLEVIN L, DURAND-GASSELIN B, CEVALLOS R et al. : Microscopic polyangiitis : clinical and laboratory findings in 85 patients. Arthritis Rheum 1999;42:421-30.
26. GUILLEVIN L, COHEN P, GAYRAUD M, LHOTE F, JARROUSSE B, CASASSUS P : Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78:26-37.
27. HOFFMAN G, SPECKS U : Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.
28. GUILLEVIN L, LHOTE F, BRAUNER M, CASASSUS P : Antineutrophil cytoplasmic antibodies (ANCA) and abnormal angiograms in polyarteritis nodosa and Churg-Strauss syndrome : indications for the diagnosis of microscopic polyangiitis. Ann Méd Interne (Paris) 1995;146:548-50.
29. PEEN E, TEJLE K, SKOGH T : Anti-granulocyte antibodies in Crohn's disease. Apmis Suppl 1990;19.
30. COHEN TERVAERT J, VAN DER WOUDE F, FAUCI A et al. : Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
31. COHEN-TERVAERT J, HUITEMA M, SLUITER W, THE T, VAN DER HEM, KALLENBERG C : Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;2:709-11.
32. EGNER W, CHAPEL HM : Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 1990;82: 244-9.
33. SPECKS U, WHEATLEY CL, MCDONALD TJ, ROHRBACH MS, DEREMEE RA : Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 1989;64:28-36.
34. KERR GS, FLEISHER TA, HALLAHAN CW, LEAVITT RY, FAUCI AS, HOFFMAN GS : Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. Adv Exp Med Biol 1993;336:411-4.
35. GUILLEVIN L, VISSER H, NOËL LH et al. : Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome : 62 patients. J Rheumatol 1993;20:1345-9.
36. COHEN P, GUILLEVIN L, BARIL L, LHOTE F, NOEL LH, LESAVRE P : Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome : follow-up of 53 patients. Clin Exp Rheumatol 1995;13:193-8.
37. KYNDT X, REUMAUX D, BRIDOUX F et al. : Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. Am J Med 1999;106:527-33.